Home Buy Trovagene To Hedge Patent Risk In Molecular Diagnostics
 

Keywords :   


Buy Trovagene To Hedge Patent Risk In Molecular Diagnostics

2013-12-26 04:33:07| Biotech - Topix.net

Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap.

Tags: buy risk patent molecular

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
More »